Our approach to research

Dynamics of sexual dimorphism across the lifespan


Many human diseases show sex biases in risk, onset and incidence. Examples include autoimmune disorders, cancer susceptibility, infectious disease incidence, and cardiovascular disease presentation and risk. In some cases, sex is a much stronger predictor of risk of or protection from disease than DNA variants. In addition, treatment responses and side effects to drugs for many disorders differ between males and females.

Sex differences are also evident in many complex human traits such as lifespan and aging, brain function, circadian rhythms, cardiovascular structure and function and immunological responses. The variety of systems exhibiting sexual dimorphisms implies that exploring these differences will afford valuable insights into disease risk and etiology and will lead to more sex-appropriate treatment options.

Our lab studies the impact of the sex chromosomes on the transcriptional and epigenetic differences between males and females in melanoma progression and outcomes. We also investigate sex biases in the transcriptome and epigenome in melanocytes, the cell of origin of melanoma. Our goal is to fully understand the ways in which sex chromosome-linked genes and their downstream targets contribute to sex differences across the lifespan, how their effects interact with hormonal effects, and how they affect the widespread sex biases in health and disease, using melanoma as a quintessential example of sex disparities.


We integrate state-of-the-art genomic and epigenomic methods in models of melanoma progression to study how sexual dimorphism is established at the molecular level. In particular, we study the dynamics of sex differences across melanocyte development and in melanoma, using mouse models to distinguish the contribution of sex chromosomes and sex hormones to sex-specific phenotypes.

We are exploiting the Four Core Genotypes mouse model, developed by Dr. Arthur Arnold, to study the independent effects of sex chromosomes and sex hormones on embryonic development. In this model, mice are produced that differ in their sex chromosome complement, while keeping sex steroid levels constant. Mice that result from the breeding scheme are XX and XY gonadal females and XX and XY gonadal males, thus uncoupling the sex chromosome composition from the hormonal environment.

We study embryogenesis beginning at stages before the gonads are developed, in which all sex differences can only be attributed to the sex chromosomes, and during subsequent development, when both sex hormones and sex chromosomes contribute to sexual dimorphism.

Click here to watch a video about the Four Core Genotypes Model

Dosage Effects of Transcription Factors

Transcription factors are overrepresented among haploinsufficient disorders, suggesting that dosage effects are important for many of them. We study whether sex differences in transcription and epigenetic factors affect their genome-wide distribution and whether their downstream targets are activated in a dosage-sensitive manner. Our lab generates male and female mouse embryonic stem cells. We have engineered tags for several sex-biased transcription factors with CRISPR/Cas technology to determine their genomic occupancy by ChIP-seq and the potential sex differences in their effects on target genes before and after differentiation into cardiac precursors.


We are grateful to the following federal agencies and private foundations for their support: National Science Foundation, W.W. Smith Charitable Trust, National Cancer Institute, the Department of Defense, and the American Cancer Society.

If you are interested in funding research that will help tailor basic and clinical studies to each gender, you can make a tax deductible donation to Corriell Institute for Medical Research for the Laboratory of Nora Engel. Funding for science at the federal level is waning and research costs are rising. Your gift will help train young scientists and advance research in sex differences in health and disease.